Anna Demchuk

Anna Demchuk

Auto-generated profile, based on publicly available information

Anna Demchuk

National Pirogov Memorial Medical University, Propedeutic Department of Internal Medicine; Department of Infection Diseases, Vinnytsya; Podilskiy Regional Oncological Center, Cytological Laboratory, Ukraine

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2024 in Reports of Vinnytsia National Medical University
Verified
Journal Article
Open access
PDF file
NON. M. Orlova
N. M. Orlova
VPV. L. Pylypchuk
V. L. Pylypchuk
ADA. V. Demchuk
A. V. Demchuk
SHS. E. Holovchanska-Pushkar
S. E. Holovchanska-Pushkar
OZO. V. Zadorozhniuk
O. V. Zadorozhniuk
LKL. A. Klimas
L. A. Klimas
Annotation. Improving control over non-communicable diseases (NCDs), which are the dominant cause of death and disability of the population of Ukraine, is an urgent problem of the national public health system. The aim of the study was to analyze the global burden of non-communicable diseases and to substantiate the possibilities of its reduction in Ukraine. The DALYs (disability adjusted life years) indicator, which considers the years of healthy life lost due to premature mortality and disability, was used to estimate the global burden of diseases. The analysis was carried out using materials from the Global Burden of Disease Study-2021 database in dynamics for 1991-2021 and in comparison, with European countries using statistical methods of standardization, dynamic, spatial, index, graphic and factor analysis. It was found that in 2021, NCDs took away more than 16.4 million years of healthy life from the population of Ukraine (38.1 thousand per 100,000 population), which accounted for 72.8% of all years lost due to disability and premature mortality. Diseases of the cardiovascular system (46.4%), neoplasms (13.6%), diseases of the musculoskeletal system (8.0%), mental disorders (6.0%), diseases of the digestive organs (5.8%), diseases of the nervous system (4.8%) took the leading places in the structure of the global burden of NCDs in Ukraine. During the entire observation period, Ukrainian age-standardized DALYs due to NCDs exceeded the similar indicator in Europe and EU countries (in 2021, by 1.3 and 1.5 times, respectively). It is shown that it is possible to significantly reduce DALYs due to NCDs in Ukraine by improving the control over modified behavioral and metabolic risk factors: by 25.8% - due to the normalization of systolic blood pressure, by 17.9% - by optimizing the diet, by 13.8% - by lowering the cholesterol level, by 11.9% - smoking cessation, 10.6% - normalization of body weight. In order to reduce the global burden of NCDs, Ukraine needs to take into account the positive experience of European countries and continue to create a modern public health system, as well as create a favorable regulatory and legal environment for the prevention of NCDs, strengthen the capacity of public health centers and communities to implement interventions to reduce risks NCDs, behavioral changes, increasing awareness and responsible attitude of the population to their health.

1 September 2015
Verified
Conference Paper
Closed access
VPVitalii Poberezhets
Vitalii Poberezhets
YMYuriy Mostovoy
Yuriy Mostovoy
HDHanna Demchuk
Hanna Demchuk
Backgroung: A lot of COPD patients suffer from obesity. This comorbidity worsens patient's condition by affecting the systemic manifestations of the disease (including skeletal muscle dysfunction (SMD)) Aim: The aim of the study was to define the features of changes in skeletal muscle and physical activity in COPD patients with obesity. Material and methods: We examined 31 male patients with COPD, mean age 58.4±8.1 years, which were divided into two groups (1 group – patients with obesity (N=13), 2 group – patients with normal weight and overweight (N=18)). Body composition (including skeletal muscle percentage, fat-free mass, fat-free mass index (FFMI), skeletal muscle index (SMI)) was calculated using bioelectrical impedance analysis). Functional status of skeletal muscle was estimated by measuring hand grip strength and 6-minute walk test distance. The level of physical activity limitation was calculated using St. George's respiratory questionnaire. Results: The values of FFMI and SMI were significantly higher in patients with obesity (20.8±1.9 kg/m2 and 9.3±1.0 kg/m2in 1 group vs 18.7±1.3kg/m2and 8.5±0.9kg/m2in 2 group, p=0.004, p=0.019). At the same time the degree of activity limitation in 1 group was higher than in 2 group (71.4±13.6 vs 58.7±14.7, p=0.04). Conclusion: Our study found that COPD patients with obesity have significantly lower extent of the SMD than patients with normal weight and overweight. But in spite of this, patients with obesity suffer from more pronounced limitation of physical activity.

9 September 2023 in Reports of Vinnytsia National Medical University
Verified
Journal Article
Open access
PDF file
ADA. Demchuk
A. Demchuk
VPVitalii Poberezhets
Vitalii Poberezhets
MTM. Tsyben
M. Tsyben
SSS. Shkondin
S. Shkondin
Annotation. A modern and effective tool for managing patients with chronic obstructive pulmonary disease (COPD) and bronchial asthma (BA) are software applications for smartphones. In order to analyze and evaluate the quality of applications for ANDROID devices available in Ukraine, which can be used by patients with BA and COPD, relevant apps were searched in the Google Play app store. We analyzed their scope, including age restrictions, number of downloads, interface language, user rating. The quality of the apps was assessed according to the guidelines of the Health and Care Mobile App Assessment Organization (ORCHA), and the reliability checklist of an untested mobile health app. We found that Ukrainians have access to 47 mobile apps for ANDROID devices to help them adapt to living with the disease. Of these, only five applications are free and in Ukrainian, but only two are software applications in terms of quality and meet the requirements of ORCHA, so may be recommended for use in patients with AD and COPD, that is insufficient to meet the needs of Ukrainian patients.